Hookipa Pharma Inc

-0.07 (-5.43%)
7:58:00 PM EDT: $1.23 +0.01 (+0.82%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)63.14M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$4.87 Million
Adjusted EPS-$0.25
See more estimates
10-Day MA$1.42
50-Day MA$1.08
200-Day MA$1.11
See more pivots

Hookipa Pharma Inc Stock, NASDAQ:HOOK

350 Fifth Avenue, 72nd Floor, Suite 7240, New York, New York 10118
United States of America
Phone: +43.1.890.6360
Number of Employees: 156


HOOKIPA Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in developing pharmaceutical products to prevent and cure infectious diseases and cancer. The firm also focuses on immunotherapeutics based on its proprietary arenavirus platform that is designed to reprogram the body�s immune system. The company was founded by Rolf M. Zinkernagel, Andreas Bergthaler, Lukas Flatz, and Daniel D. Pinschewer in 2011 and is headquartered in New York, NY.